As of Dec 15
| 0.00 / 0.00%|
The 14 analysts offering 12-month price forecasts for Ionis Pharmaceuticals Inc have a median target of 56.50, with a high estimate of 113.00 and a low estimate of 18.00. The median estimate represents a +7.76% increase from the last price of 52.43.
The current consensus among 15 polled investment analysts is to Hold stock in Ionis Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.